Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 30, 2006
Stem Cells Vol. 25 No. 3 March 2007, pp. 771 -778
doi:10.1634/stemcells.2006-0271; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2006-0271v1
25/3/771    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chadalavada, R. S. V.
Right arrow Articles by Chaganti, R. S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chadalavada, R. S. V.
Right arrow Articles by Chaganti, R. S. K.

STEM CELL GENETICS AND GENOMICS

Constitutive Gene Expression Predisposes Morphogen-Mediated Cell Fate Responses of NT2/D1 and 27X-1 Human Embryonal Carcinoma Cells

Rajendrakumar S. V. Chadalavadaa, James E. Korkolaa, Jane Houldswortha,b, Adam B. Olshenc, George J. Boslb, Lorenz Studerd,e, R. S. K. Chagantia,b

aCell Biology Program,
bDepartment of Medicine,
cDepartment of Epidemiology and Biostatistics,
dDevelopmental Biology Program, and
eDivision of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Key Words. Germ cell tumors • Embryonal carcinoma • Pluripotent • Yolk sac cell • ATRA • BMP-2

Correspondence: R.S.K. Chaganti, Ph.D., Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA. Telephone: 212/639-8121; Fax: 212/717-3541; e-mail: chagantr{at}mskcc.org

Received May 4, 2006; accepted for publication November 17, 2006.
First published online in STEM CELLS EXPRESS   November 30, 2006.



Human embryonal carcinoma (EC) cell lines exhibit considerable heterogeneity in their levels of pluripotency. Thus, NT2/D1 cells differentiate into neural lineages upon exposure to all-trans retinoic acid (ATRA) and non-neural epithelial lineages upon exposure to bone morphogenetic protein-2 (BMP-2). In contrast, 27X-1 cells differentiate into extra-embryonic endodermal (ExE) cells upon treatment with either morphogen. To understand the molecular basis for the differential responses of the two cell lines, we performed gene expression profiling at the undifferentiated EC cell line state to identify constitutive differences in gene expression. NT2/D1 cells preferentially expressed transcripts associated with neurectodermal development, whereas 27X-1 cells expressed high levels of transcripts associated with mesendodermal characteristics. We then determined temporal expression profiles of 27X-1 cells during ExE differentiation upon treatment with ATRA and BMP-2 and compared the data with changes in gene expression observed during BMP-2- and ATRA-induced differentiation of NT2/D1 cells. ATRA and BMP-2 induced distinct sets of transcription factors and phenotypic markers in the two EC cell lines, underlying distinct lineage choices. Although 27X-1 differentiation yielded comprehensive gene expression profiles of parietal endodermal lineages, we were able to use the combined analysis of 27X-1 data with data derived from yolk sac tumors for the identification of transcripts associated with visceral endoderm formation. Our results demonstrate constitutive differences in the levels of pluripotency between NT2/D1 and 27X-1 cells that correlate with lineage potential. This study also demonstrates that EC cells can serve as robust models to investigate early lineage choices during both embryonic and extra-embryonic human development.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Roach, K. D. Smith, K. L. Strobe, S. M. Nissen, C. D. Haudenschild, D. Zhou, T. J. Vasicek, G. A. Held, G. A. Stolovitzky, L. E. Hood, et al.
Transcription factor expression in lipopolysaccharide-activated peripheral-blood-derived mononuclear cells
PNAS, October 9, 2007; 104(41): 16245 - 16250.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
I. Gashaw, O. Dushaj, R. Behr, K. Biermann, R. Brehm, H. Rubben, R. Grobholz, K. W. Schmid, M. Bergmann, and E. Winterhager
Novel germ cell markers characterize testicular seminoma and fetal testis
Mol. Hum. Reprod., October 1, 2007; 13(10): 721 - 727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 2007 by AlphaMed Press.